Skip to content

Calumet, Inc. CLMT Accrued Employee Benefits (Non-Current)

Accrued Employee Benefits (Non-Current) at other companies

Eastman Chemical logo
Eastman ChemicalEMN
$400M-35.9%

Other financials

Income statement

See full
Revenue$1.0B+3.6%
Gross profit-$87.5M-7.5%
Operating income-$171.3M-252%
Net income-$317.0M-95.7%
EPS (diluted)-$3.64-94.7%

Balance sheet

See full
Cash & equivalents$138.6M+12.3%
Total debt$2.3B-9.0%
Total equity-$1.0B-21.0%
Total assets$2.8B-2.4%

Cash flow

See full
Operating cash flow-$86.2M-194%
CapEx$13.2M-25.0%
Free cash flow-$99.4M-112%

Valuation

See full
Market cap$2.86B+185%
Enterprise value$5.06B+50.3%
P/S0.7×+0.4×

Profitability

See full
Gross margin5.8%+4.1pp
Operating margin4.8%
Net margin-4.5%-1.4pp
FCF margin0.1%

Returns & leverage

See full
Return on equity19.8%
Debt / equity-2.2×
Current ratio-0.1×

Where this comes from

Reported directly by Calumet, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesNoncurrent.

The official record: Calumet, Inc.’s 10-K, filed February 27, 2026, on SEC EDGAR. View the filing →

Ask your AI about Calumet, Inc.'s accrued employee benefits (non-current).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Calumet, Inc.'s accrued employee benefits (non-current)?
Calumet, Inc. (CLMT) reported accrued employee benefits (non-current) of $3.8M in Q4 2025.
What is the long-term trend for Calumet, Inc.'s accrued employee benefits (non-current)?
Over 2 years (2023 to 2025), Calumet, Inc.'s accrued employee benefits (non-current) has grown at a -4.9% compound annual growth rate (CAGR), from $4.2M to $3.8M.
What does accrued employee benefits (non-current) mean?
This represents the long-term portion of obligations owed to employees for retirement benefits, pension plans, or deferred compensation. It reflects the company's future financial commitment to its workforce beyond the upcoming fiscal year. These liabilities are critical for assessing the long-term solvency and pension funding status of capital-intensive firms.